Molecular imaging provides in-depth view of tumors

07/12/2007 | M.I.T. Technology Review

Molecular imaging technology is showing promise as a technique for earlier disease diagnosis, more accurate prediction of the spread of disease and better understanding of the effects of drugs on the body. The technique, which enables a deeper view into tissue and chemical activity within the body than conventional imaging such as MRI, was developed by VisEn Medical, which is collaborating with pharmaceutical firms such as Merck and Eli Lilly. VisEn is applying for FDA permission to test the method on humans.

View Full Article in:

M.I.T. Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA